398 related articles for article (PubMed ID: 28340987)
1. Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.
Ao GZ; Zhou MZ; Li YY; Li SN; Wang HN; Wan QW; Li HQ; Hu QH
Bioorg Med Chem; 2017 Jan; 25(1):166-174. PubMed ID: 28340987
[TBL] [Abstract][Full Text] [Related]
2. (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1.
Hu Q; Zhou M; Zhu H; Lu G; Zheng D; Li H; Hao K
Biomed Pharmacother; 2017 Feb; 86():88-94. PubMed ID: 27951420
[TBL] [Abstract][Full Text] [Related]
3. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
[TBL] [Abstract][Full Text] [Related]
4. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
Chen G; Tan ML; Li KK; Leung PC; Ko CH
J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
[TBL] [Abstract][Full Text] [Related]
5. Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia.
Zheng F; Mai S; Cen X; Zhao P; Ye W; Ke J; Lin S; Hu H; Guo Z; Zhang S; Liao H; Wu T; Tian Y; Zhang Q; Pang J; Zhao Z
Bioorg Chem; 2024 Jun; 147():107381. PubMed ID: 38669781
[TBL] [Abstract][Full Text] [Related]
6. Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1.
Oh DR; Kim JR; Choi CY; Choi CH; Na CS; Kang BY; Kim SJ; Kim YR
BMC Complement Altern Med; 2019 Jan; 19(1):10. PubMed ID: 30621705
[TBL] [Abstract][Full Text] [Related]
7. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S
Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid phenethyl ester alleviated hypouricemia in hyperuricemic mice through inhibiting XOD and up-regulating OAT3.
Yong T; Liang D; Chen S; Xiao C; Gao X; Wu Q; Xie Y; Huang L; Hu H; Li X; Liu Y; Cai M
Phytomedicine; 2022 Aug; 103():154256. PubMed ID: 35714456
[TBL] [Abstract][Full Text] [Related]
9. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019).
Dong Y; Zhao T; Ai W; Zalloum WA; Kang D; Wu T; Liu X; Zhan P
Expert Opin Ther Pat; 2019 Nov; 29(11):871-879. PubMed ID: 31593642
[No Abstract] [Full Text] [Related]
10. DKB114, A Mixture of
Lee YS; Kim SH; Yuk HJ; Kim DS
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
[No Abstract] [Full Text] [Related]
11. Anti-hyperuricemic effect of Alpinia oxyphylla seed extract by enhancing uric acid excretion in the kidney.
Lee YS; Sung YY; Yuk HJ; Son E; Lee S; Kim JS; Kim DS
Phytomedicine; 2019 Sep; 62():152975. PubMed ID: 31181404
[TBL] [Abstract][Full Text] [Related]
12. Anti-hyperuricemic and nephroprotective effects of Modified Simiao Decoction in hyperuricemic mice.
Hua J; Huang P; Zhu CM; Yuan X; Yu CH
J Ethnopharmacol; 2012 Jun; 142(1):248-52. PubMed ID: 22575704
[TBL] [Abstract][Full Text] [Related]
13. Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition.
Lin H; Tu C; Niu Y; Li F; Yuan L; Li N; Xu A; Gao L; Li L
Eur J Pharmacol; 2019 Jun; 853():371-380. PubMed ID: 31009635
[TBL] [Abstract][Full Text] [Related]
14. Uricosuric drugs: the once and future therapy for hyperuricemia?
Bach MH; Simkin PA
Curr Opin Rheumatol; 2014 Mar; 26(2):169-75. PubMed ID: 24445479
[TBL] [Abstract][Full Text] [Related]
15. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice.
Wang R; Ma CH; Zhou F; Kong LD
Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200
[TBL] [Abstract][Full Text] [Related]
16. Modified Chuanhu anti-gout mixture, a traditional Chinese medicine, protects against potassium oxonate-induced hyperuricemia and renal dysfunction in mice.
You W; Wang J; Zou Y; Che K; Hou X; Fei H; Wang Y
J Int Med Res; 2019 May; 47(5):1927-1935. PubMed ID: 30832523
[TBL] [Abstract][Full Text] [Related]
17. CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
Zhao ZA; Jiang Y; Chen YY; Wu T; Lan QS; Li YM; Li L; Yang Y; Lin CT; Cao Y; Zhou PZ; Guo JY; Tian YX; Pang JX
Acta Pharmacol Sin; 2022 Jan; 43(1):121-132. PubMed ID: 33767379
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of 3-phenyl substituted pyridine derivatives as potential dual inhibitors of XOR and URAT1.
Yang C; Cai H; Zhu X; Zhang L; Li J
Eur J Med Chem; 2024 May; 271():116407. PubMed ID: 38663283
[TBL] [Abstract][Full Text] [Related]
19. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
Zhou M; Li S; Song L; Hu Q; Liu W
Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
[TBL] [Abstract][Full Text] [Related]
20. Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models.
Li X; Yan Z; Tian J; Zhang X; Han H; Ye F
Ann Clin Lab Sci; 2019 Nov; 49(6):756-762. PubMed ID: 31882426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
